1.73
price up icon12.34%   0.19
after-market Handel nachbörslich: 1.71 -0.02 -1.16%
loading

Gain Therapeutics Inc Aktie (GANX) Neueste Nachrichten

pulisher
08:16 AM

Short Term Trend Reversal in Gain Therapeutics Inc. Possible2025 Trading Volume Trends & Smart Money Movement Alerts - beatles.ru

08:16 AM
pulisher
08:02 AM

Published on: 2025-08-15 07:02:29 - Newser

08:02 AM
pulisher
06:46 AM

Chart overlay techniques for tracking Gain Therapeutics Inc.2025 Technical Overview & Weekly Watchlist for Hot Stocks - Newser

06:46 AM
pulisher
05:47 AM

Is Gain Therapeutics Inc. forming a reversal patternPortfolio Return Summary & Risk Adjusted Buy and Sell Alerts - Newser

05:47 AM
pulisher
04:33 AM

Using data models to predict Gain Therapeutics Inc. stock movementWeekly Risk Summary & Daily Oversold Stock Bounce Ideas - Newser

04:33 AM
pulisher
Aug 14, 2025

Using flow based indicators on Gain Therapeutics Inc.July 2025 Summary & Scalable Portfolio Growth Methods - Newser

Aug 14, 2025
pulisher
Aug 14, 2025

Buy Recommendation for Gain Therapeutics Based on Parkinson's Drug Development and Strong Financial Position - AInvest

Aug 14, 2025
pulisher
Aug 14, 2025

Why Gain Therapeutics Inc. stock attracts strong analyst attentionQuarterly Risk Review & Weekly Top Gainers Trade List - Newser

Aug 14, 2025
pulisher
Aug 14, 2025

Gain Therapeutics (NASDAQ:GANX) Given New $6.00 Price Target at Roth Capital - Defense World

Aug 14, 2025
pulisher
Aug 13, 2025

Gain Therapeutics, Inc. shares rise 3.27% intraday after Perspective Therapeutics presented positive [212Pb]VMT-α-NET study update at ASCO Annual Meeting. - AInvest

Aug 13, 2025
pulisher
Aug 13, 2025

Intraday Charts Show Spike in Gain Therapeutics Inc. ActivityBond Market & Smart Swing Trading Alerts - sundaytimes.kr

Aug 13, 2025
pulisher
Aug 13, 2025

Has Gain Therapeutics Inc. found a price floorWeekly Investment Report & Community Trade Idea Sharing - Newser

Aug 13, 2025
pulisher
Aug 13, 2025

What analysts say about Gain Therapeutics Inc. stock outlookMarket Activity Report & Daily Profit Focused Screening - Newser

Aug 13, 2025
pulisher
Aug 12, 2025

What analysts say about Gain Therapeutics Inc. stock outlook [2025 Market Sentiment]High Accuracy Investment Signals - Newser

Aug 12, 2025
pulisher
Aug 12, 2025

Gain Therapeutics Inc.’s Price Action Aligns with Quant SignalsReal-Time Analysis With Entry Targets In Progress - 선데이타임즈

Aug 12, 2025
pulisher
Aug 12, 2025

Gain Therapeutics completes Q2 2025 with Phase 1b enrolment, $7.1mln in net proceeds. - AInvest

Aug 12, 2025
pulisher
Aug 12, 2025

Gain Therapeutics, Inc. shares rise 4.11% intraday after Aardvark Therapeutics reports positive ARD-201 preclinical results. - AInvest

Aug 12, 2025
pulisher
Aug 12, 2025

Gain Therapeutics Fast-Tracks Parkinson's Drug Trial: Key Results Coming Q4 2025, Raises $7.1M - Stock Titan

Aug 12, 2025
pulisher
Aug 11, 2025

Gain Therapeutics GANX 2025Q2 Earnings Preview Upside Potential on Robust Revenue Growth - AInvest

Aug 11, 2025
pulisher
Aug 11, 2025

Analyzing recovery setups for Gain Therapeutics Inc. investorsTrade Safety Report with Pattern Insights - Newser

Aug 11, 2025
pulisher
Aug 09, 2025

Healthcare Stocks in Focus: Gainers and Losers in Friday's After-Market Session - AInvest

Aug 09, 2025
pulisher
Aug 08, 2025

Visualizing Gain Therapeutics Inc. stock with heatmapsConsistent Return Setup with Exit Strategy - Newser

Aug 08, 2025
pulisher
Aug 07, 2025

Best data tools to analyze Gain Therapeutics Inc. stockGrowth Watchlist for Long Term Positioning - Newser

Aug 07, 2025
pulisher
Aug 07, 2025

Gain Therapeutics, Inc. (NASDAQ:GANX) Receives $8.20 Average Target Price from Analysts - Defense World

Aug 07, 2025
pulisher
Aug 07, 2025

Gain Therapeutics (GANX) Projected to Post Earnings on Thursday - Defense World

Aug 07, 2025
pulisher
Aug 06, 2025

What makes Gain Therapeutics Inc. stock price move sharplyGrowth Summary Based on Market Positioning - Newser

Aug 06, 2025
pulisher
Aug 06, 2025

Candlestick signals on Gain Therapeutics Inc. stock todayMarket Stability and Long-Term Growth Outlook - Newser

Aug 06, 2025
pulisher
Aug 04, 2025

Gain Therapeutics Inc expected to post a loss of 17 cents a shareEarnings Preview - TradingView

Aug 04, 2025
pulisher
Aug 04, 2025

What technical models suggest about Alaunos Therapeutics Inc.’s comebackWeekly Signal Report with Trend Summary - Newser

Aug 04, 2025
pulisher
Aug 03, 2025

What is the dividend policy of Gain Therapeutics Inc. stockConsistent wealth multiplication - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Should I hold or sell Gain Therapeutics Inc. stock in 2025Discover breakthrough investment opportunities - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Is Gain Therapeutics Inc. a good long term investmentAchieve breakthrough financial results today - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Is Gain Therapeutics Inc. stock overvalued or undervaluedMaximize returns with disciplined trading approaches - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What catalysts could drive Gain Therapeutics Inc. stock higher in 2025Capitalize on high-yield stocks early - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Evaluating Gain Therapeutics Inc. with trendline analysisPortfolio Review Summary with Five-Year Outlook - Newser

Aug 03, 2025
pulisher
Aug 03, 2025

What are analysts’ price targets for Gain Therapeutics Inc. in the next 12 monthsHigh-velocity gains - Jammu Links News

Aug 03, 2025
$36.34
price down icon 0.44%
$86.92
price up icon 0.88%
$26.69
price up icon 0.91%
$127.80
price up icon 0.04%
$113.52
price up icon 0.73%
biotechnology ONC
$321.36
price up icon 3.77%
Kapitalisierung:     |  Volumen (24h):